Page last updated: 2024-10-31

nafamostat and Pain

nafamostat has been researched along with Pain in 3 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Research Excerpts

ExcerptRelevanceReference
"To elucidate the mechanism of propofol-induced pain on injection, we performed several studies using nafamostat mesilate, a kallikrein inhibitor, or lidocaine."9.09A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate. ( Iwama, H; Nakane, M, 1999)
"We have examined the preventative effect of nafamostat mesilate, a kallikrein inhibitor, on pain on injection with propofol in a randomized, double-blind study."9.08Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol. ( Iwama, H; Kaneko, T; Kato, M; Nakane, M; Ohmori, S; Okuaki, A; Watanabe, K, 1998)
"To elucidate the mechanism of propofol-induced pain on injection, we performed several studies using nafamostat mesilate, a kallikrein inhibitor, or lidocaine."5.09A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate. ( Iwama, H; Nakane, M, 1999)
"We have examined the preventative effect of nafamostat mesilate, a kallikrein inhibitor, on pain on injection with propofol in a randomized, double-blind study."5.08Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol. ( Iwama, H; Kaneko, T; Kato, M; Nakane, M; Ohmori, S; Okuaki, A; Watanabe, K, 1998)
"The established referred allodynia/hyperalgesia following cerulein treatment was abolished by post-treatment with nafamostat mesilate, a proteinase inhibitor, and with capsazepine, a TRPV1 antagonist, in mice."3.76The proteinase/proteinase-activated receptor-2/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in mice. ( Akashi, R; Ishikura, H; Kawabata, A; Kitamura, T; Matsumura, K; Matsunami, M; Naruse, M; Nishimura, S; Sekiguchi, F; Shinozaki, Y, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishimura, S1
Ishikura, H1
Matsunami, M1
Shinozaki, Y1
Sekiguchi, F1
Naruse, M1
Kitamura, T1
Akashi, R1
Matsumura, K1
Kawabata, A1
Iwama, H2
Nakane, M2
Ohmori, S1
Kaneko, T1
Kato, M1
Watanabe, K1
Okuaki, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Large Antecubital Vein Versus Small Vein on Dorsum of Hand for the Prevention of Propofol Injection Pain[NCT04673500]160 participants (Actual)Interventional2013-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for nafamostat and Pain

ArticleYear
Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol.
    British journal of anaesthesia, 1998, Volume: 81, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Benzamidines; Double-Blind Met

1998
A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate.
    British journal of anaesthesia, 1999, Volume: 83, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Anesthetics, Local; Benzamidin

1999

Other Studies

1 other study available for nafamostat and Pain

ArticleYear
The proteinase/proteinase-activated receptor-2/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in mice.
    Life sciences, 2010, Nov-20, Volume: 87, Issue:19-22

    Topics: Acute Disease; Animals; Benzamidines; Capsaicin; Ceruletide; Disease Models, Animal; Gene Expression

2010